| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mustard Gas | 14 | 2016 | 31 | 4.030 |
Why?
|
| Lung | 25 | 2014 | 413 | 3.210 |
Why?
|
| Diacylglycerol Cholinephosphotransferase | 16 | 2012 | 30 | 2.800 |
Why?
|
| Guinea Pigs | 37 | 2016 | 141 | 1.990 |
Why?
|
| Antioxidants | 8 | 2016 | 386 | 1.830 |
Why?
|
| Lung Injury | 4 | 2016 | 12 | 1.640 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2010 | 70 | 1.260 |
Why?
|
| Receptors, GABA-A | 7 | 2010 | 60 | 1.170 |
Why?
|
| Liposomes | 6 | 2016 | 107 | 1.130 |
Why?
|
| Chemical Warfare Agents | 4 | 2011 | 12 | 1.110 |
Why?
|
| Animals | 53 | 2016 | 14307 | 0.950 |
Why?
|
| Tretinoin | 2 | 2014 | 50 | 0.880 |
Why?
|
| Benzodiazepinones | 9 | 2012 | 21 | 0.830 |
Why?
|
| Acetylcysteine | 3 | 2009 | 58 | 0.790 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2003 | 45 | 0.770 |
Why?
|
| Lung Diseases | 4 | 2006 | 56 | 0.750 |
Why?
|
| Receptors, GABA | 2 | 2012 | 22 | 0.700 |
Why?
|
| Phosphotransferases | 3 | 2014 | 35 | 0.700 |
Why?
|
| Transcription Factor AP-1 | 2 | 2009 | 33 | 0.680 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 5 | 2010 | 28 | 0.640 |
Why?
|
| Soybean Proteins | 2 | 2008 | 38 | 0.610 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 24 | 0.600 |
Why?
|
| Signal Transduction | 3 | 2014 | 1802 | 0.580 |
Why?
|
| Carrier Proteins | 2 | 2010 | 287 | 0.560 |
Why?
|
| Breast Neoplasms | 4 | 2012 | 1426 | 0.540 |
Why?
|
| Receptors, Adrenergic, beta | 3 | 2009 | 33 | 0.520 |
Why?
|
| Erythrocytes | 5 | 2011 | 107 | 0.510 |
Why?
|
| Retinoids | 1 | 2014 | 28 | 0.510 |
Why?
|
| Microsomes | 6 | 2005 | 52 | 0.490 |
Why?
|
| Male | 31 | 2016 | 18870 | 0.460 |
Why?
|
| Carcinogens | 4 | 2008 | 117 | 0.450 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 756 | 0.450 |
Why?
|
| Models, Biological | 2 | 2014 | 642 | 0.440 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 143 | 0.440 |
Why?
|
| Lactoylglutathione Lyase | 2 | 2002 | 4 | 0.430 |
Why?
|
| Thiolester Hydrolases | 2 | 2002 | 6 | 0.430 |
Why?
|
| Cell Proliferation | 4 | 2012 | 1149 | 0.430 |
Why?
|
| Superoxide Dismutase | 7 | 2006 | 149 | 0.420 |
Why?
|
| Liver | 5 | 2002 | 447 | 0.420 |
Why?
|
| Smoking | 3 | 2007 | 903 | 0.410 |
Why?
|
| Blotting, Western | 7 | 2010 | 834 | 0.410 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 160 | 0.390 |
Why?
|
| Epithelial Cells | 2 | 2004 | 366 | 0.370 |
Why?
|
| Isoquinolines | 1 | 2010 | 40 | 0.370 |
Why?
|
| Brain Injuries | 1 | 2011 | 104 | 0.360 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2010 | 1534 | 0.360 |
Why?
|
| Mitochondria | 6 | 2001 | 454 | 0.360 |
Why?
|
| Antidotes | 1 | 2009 | 3 | 0.360 |
Why?
|
| Pulmonary Alveoli | 3 | 2002 | 26 | 0.360 |
Why?
|
| Kidney | 2 | 2002 | 322 | 0.350 |
Why?
|
| Phosphatidylcholines | 3 | 2005 | 45 | 0.350 |
Why?
|
| Rats | 11 | 2010 | 3261 | 0.350 |
Why?
|
| Tocopherols | 1 | 2009 | 62 | 0.340 |
Why?
|
| Lutein | 1 | 2008 | 4 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 122 | 0.340 |
Why?
|
| Free Radical Scavengers | 2 | 2003 | 65 | 0.330 |
Why?
|
| Triiodothyronine | 3 | 2001 | 30 | 0.330 |
Why?
|
| Brain | 4 | 2011 | 1268 | 0.310 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 396 | 0.300 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 162 | 0.290 |
Why?
|
| Endothelium, Vascular | 2 | 2001 | 229 | 0.290 |
Why?
|
| Anthracenes | 1 | 2006 | 13 | 0.290 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 522 | 0.290 |
Why?
|
| Dietary Proteins | 1 | 2006 | 30 | 0.290 |
Why?
|
| Sequence Alignment | 2 | 2003 | 257 | 0.280 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 30 | 0.280 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2005 | 14 | 0.280 |
Why?
|
| Inflammation | 1 | 2010 | 577 | 0.270 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 122 | 0.270 |
Why?
|
| Breast | 2 | 2006 | 134 | 0.270 |
Why?
|
| Dopamine | 1 | 2007 | 232 | 0.260 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 2010 | 42 | 0.260 |
Why?
|
| Transcription Factors | 1 | 2010 | 653 | 0.260 |
Why?
|
| Oleic Acids | 2 | 1994 | 12 | 0.250 |
Why?
|
| Anilides | 2 | 1994 | 27 | 0.250 |
Why?
|
| Alopecia | 1 | 2004 | 9 | 0.240 |
Why?
|
| Hair | 1 | 2004 | 20 | 0.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2009 | 325 | 0.240 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 239 | 0.240 |
Why?
|
| Cadmium | 1 | 2004 | 56 | 0.240 |
Why?
|
| Mammary Glands, Human | 1 | 2004 | 39 | 0.240 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 310 | 0.230 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 66 | 0.230 |
Why?
|
| Vitamin A Deficiency | 2 | 1996 | 14 | 0.230 |
Why?
|
| Phospholipids | 2 | 2002 | 68 | 0.220 |
Why?
|
| Thyronines | 1 | 2002 | 1 | 0.220 |
Why?
|
| Sickle Cell Trait | 2 | 1993 | 18 | 0.220 |
Why?
|
| Pyrazines | 1 | 2002 | 23 | 0.210 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 57 | 0.210 |
Why?
|
| Diet | 1 | 2008 | 747 | 0.210 |
Why?
|
| Female | 14 | 2013 | 19873 | 0.210 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 3 | 1994 | 5 | 0.210 |
Why?
|
| Calcium | 2 | 2002 | 445 | 0.210 |
Why?
|
| Smoke | 1 | 2002 | 39 | 0.210 |
Why?
|
| Anticarcinogenic Agents | 1 | 2002 | 65 | 0.210 |
Why?
|
| Erythrocyte Membrane | 2 | 1999 | 20 | 0.210 |
Why?
|
| Antibody Specificity | 1 | 2001 | 75 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 984 | 0.200 |
Why?
|
| Tissue Distribution | 3 | 2011 | 197 | 0.200 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 61 | 0.200 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 103 | 0.200 |
Why?
|
| Oligopeptides | 1 | 2001 | 97 | 0.200 |
Why?
|
| Drug Carriers | 1 | 2002 | 121 | 0.190 |
Why?
|
| Protein Kinase C | 1 | 2001 | 110 | 0.190 |
Why?
|
| Lipid Peroxidation | 4 | 2006 | 131 | 0.190 |
Why?
|
| Base Sequence | 4 | 2005 | 932 | 0.190 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 5 | 0.180 |
Why?
|
| Nucleoside-Triphosphatase | 2 | 2012 | 4 | 0.180 |
Why?
|
| Macrophages, Alveolar | 1 | 1999 | 31 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 605 | 0.180 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2011 | 45 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 336 | 0.180 |
Why?
|
| Asthma | 1 | 2003 | 363 | 0.180 |
Why?
|
| Pulmonary Surfactants | 1 | 1999 | 26 | 0.180 |
Why?
|
| Ceramides | 3 | 2005 | 41 | 0.170 |
Why?
|
| Peptide Fragments | 1 | 2001 | 298 | 0.170 |
Why?
|
| Cyclin D1 | 2 | 2009 | 42 | 0.170 |
Why?
|
| Cholera Toxin | 3 | 2009 | 34 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2009 | 74 | 0.170 |
Why?
|
| Humans | 14 | 2014 | 34853 | 0.170 |
Why?
|
| Cholesterol | 2 | 2012 | 194 | 0.160 |
Why?
|
| Cyclic AMP | 3 | 2009 | 125 | 0.160 |
Why?
|
| Obesity | 1 | 2005 | 965 | 0.160 |
Why?
|
| Cell Nucleus | 2 | 2012 | 351 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 406 | 0.150 |
Why?
|
| Administration, Inhalation | 2 | 2010 | 75 | 0.150 |
Why?
|
| Exercise | 2 | 1993 | 524 | 0.150 |
Why?
|
| Oxidative Stress | 3 | 2011 | 874 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 628 | 0.150 |
Why?
|
| Microscopy, Electron | 4 | 2005 | 186 | 0.150 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 53 | 0.150 |
Why?
|
| Ligands | 2 | 2008 | 317 | 0.140 |
Why?
|
| Microsomes, Liver | 2 | 2001 | 69 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 480 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2006 | 1152 | 0.140 |
Why?
|
| Adrenal Medulla | 1 | 1994 | 14 | 0.130 |
Why?
|
| Time Factors | 2 | 2010 | 1681 | 0.130 |
Why?
|
| Blood Proteins | 2 | 2009 | 65 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 968 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 58 | 0.130 |
Why?
|
| Vitamin A | 1 | 1995 | 87 | 0.130 |
Why?
|
| Linoleic Acids | 1 | 1994 | 3 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 1490 | 0.120 |
Why?
|
| Acne Vulgaris | 1 | 2013 | 7 | 0.120 |
Why?
|
| Hyperpigmentation | 1 | 2013 | 10 | 0.120 |
Why?
|
| Dihydroalprenolol | 2 | 2009 | 6 | 0.120 |
Why?
|
| Thyroid Hormones | 1 | 1993 | 26 | 0.120 |
Why?
|
| Free Radicals | 3 | 2003 | 72 | 0.120 |
Why?
|
| Tritium | 2 | 2008 | 48 | 0.120 |
Why?
|
| Kinetics | 3 | 2007 | 650 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2003 | 9 | 0.110 |
Why?
|
| Cell Line | 3 | 2004 | 1289 | 0.110 |
Why?
|
| Annexins | 1 | 1992 | 7 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2003 | 52 | 0.110 |
Why?
|
| Body Weight | 3 | 2005 | 404 | 0.110 |
Why?
|
| Caspases | 2 | 2003 | 132 | 0.110 |
Why?
|
| GABA Agonists | 1 | 2012 | 21 | 0.110 |
Why?
|
| Blood Cell Count | 1 | 1992 | 13 | 0.110 |
Why?
|
| Neoplasms | 1 | 2002 | 1033 | 0.110 |
Why?
|
| Hydrogen Peroxide | 1 | 1993 | 181 | 0.110 |
Why?
|
| Trachea | 1 | 2011 | 19 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 1993 | 137 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2003 | 161 | 0.100 |
Why?
|
| Permeability | 1 | 2011 | 67 | 0.100 |
Why?
|
| Aging | 2 | 1993 | 639 | 0.100 |
Why?
|
| Carbon Dioxide | 1 | 1992 | 78 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 608 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2011 | 48 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2010 | 3 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2010 | 17 | 0.100 |
Why?
|
| Submandibular Gland | 1 | 1990 | 3 | 0.100 |
Why?
|
| Isoproterenol | 2 | 2001 | 35 | 0.100 |
Why?
|
| Aerosols | 1 | 2010 | 48 | 0.100 |
Why?
|
| Pregnancy, Animal | 1 | 1990 | 16 | 0.100 |
Why?
|
| Oxygen | 1 | 1992 | 193 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1124 | 0.090 |
Why?
|
| Mitochondria, Liver | 1 | 1990 | 15 | 0.090 |
Why?
|
| Models, Animal | 1 | 2010 | 131 | 0.090 |
Why?
|
| Annexin A5 | 1 | 2010 | 24 | 0.090 |
Why?
|
| Glutathione Peroxidase | 4 | 2006 | 109 | 0.090 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 32 | 0.090 |
Why?
|
| NF-kappa B | 2 | 2003 | 306 | 0.090 |
Why?
|
| Submitochondrial Particles | 1 | 1989 | 5 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 66 | 0.090 |
Why?
|
| Catalase | 4 | 2006 | 106 | 0.090 |
Why?
|
| Meclofenoxate | 1 | 1989 | 2 | 0.090 |
Why?
|
| Glycolates | 1 | 1989 | 6 | 0.090 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2009 | 4 | 0.090 |
Why?
|
| Activating Transcription Factors | 1 | 2009 | 4 | 0.090 |
Why?
|
| Embryonic and Fetal Development | 1 | 1989 | 37 | 0.090 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1989 | 29 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2010 | 140 | 0.090 |
Why?
|
| Apoptosis | 2 | 2010 | 1317 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 26 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 24 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 157 | 0.090 |
Why?
|
| Membranes | 1 | 2009 | 18 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2009 | 35 | 0.090 |
Why?
|
| Gene Expression | 1 | 2012 | 639 | 0.090 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2008 | 4 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 247 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2010 | 309 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 1300 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2010 | 628 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2002 | 48 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 2128 | 0.080 |
Why?
|
| Cell Division | 2 | 2002 | 296 | 0.080 |
Why?
|
| Polymyxins | 1 | 1987 | 1 | 0.080 |
Why?
|
| Polymyxin B | 1 | 1987 | 7 | 0.080 |
Why?
|
| Actins | 1 | 2008 | 142 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2005 | 423 | 0.080 |
Why?
|
| Dactinomycin | 2 | 2002 | 12 | 0.080 |
Why?
|
| Acyltransferases | 1 | 1987 | 21 | 0.080 |
Why?
|
| Cycloheximide | 2 | 2002 | 30 | 0.080 |
Why?
|
| Adrenergic beta-Agonists | 2 | 1999 | 27 | 0.080 |
Why?
|
| Phenotype | 1 | 2010 | 650 | 0.080 |
Why?
|
| Food | 1 | 2008 | 95 | 0.080 |
Why?
|
| Motor Activity | 2 | 2007 | 393 | 0.080 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2007 | 27 | 0.080 |
Why?
|
| Cattle | 2 | 2001 | 472 | 0.070 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2007 | 35 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 407 | 0.070 |
Why?
|
| Cell Movement | 1 | 2010 | 545 | 0.070 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2007 | 68 | 0.070 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2006 | 32 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2009 | 878 | 0.070 |
Why?
|
| Biological Transport | 1 | 2006 | 175 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 269 | 0.070 |
Why?
|
| Benzo(a)pyrene | 1 | 2006 | 122 | 0.070 |
Why?
|
| DNA | 1 | 2008 | 549 | 0.070 |
Why?
|
| Protein Binding | 1 | 2008 | 913 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2005 | 139 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 269 | 0.060 |
Why?
|
| Environmental Pollutants | 1 | 2006 | 166 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2003 | 34 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 42 | 0.060 |
Why?
|
| Risk Factors | 1 | 2012 | 3414 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2004 | 87 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2003 | 49 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2005 | 420 | 0.060 |
Why?
|
| Species Specificity | 1 | 2003 | 233 | 0.060 |
Why?
|
| Erythrocyte Count | 2 | 1993 | 11 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2003 | 22 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 67 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 84 | 0.060 |
Why?
|
| RNA Probes | 1 | 2002 | 10 | 0.050 |
Why?
|
| Thiones | 1 | 2002 | 2 | 0.050 |
Why?
|
| Enzyme Induction | 1 | 2002 | 48 | 0.050 |
Why?
|
| Annexin A1 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 485 | 0.050 |
Why?
|
| Pyruvaldehyde | 1 | 2002 | 4 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2002 | 33 | 0.050 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 2 | 1993 | 9 | 0.050 |
Why?
|
| Thiophenes | 1 | 2002 | 31 | 0.050 |
Why?
|
| NADP | 2 | 1993 | 24 | 0.050 |
Why?
|
| Serotonin | 1 | 2001 | 114 | 0.050 |
Why?
|
| Pregnancy | 3 | 1991 | 1503 | 0.050 |
Why?
|
| Cell Survival | 1 | 2004 | 818 | 0.050 |
Why?
|
| Rats, Inbred Strains | 2 | 1990 | 132 | 0.050 |
Why?
|
| Aorta | 1 | 2001 | 161 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 123 | 0.050 |
Why?
|
| Lipids | 1 | 2002 | 222 | 0.050 |
Why?
|
| Protein Transport | 1 | 2001 | 286 | 0.050 |
Why?
|
| Subcellular Fractions | 2 | 1990 | 72 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 193 | 0.050 |
Why?
|
| Epinephrine | 1 | 1999 | 35 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 781 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 22 | 0.040 |
Why?
|
| Densitometry | 1 | 1999 | 13 | 0.040 |
Why?
|
| Water | 1 | 2002 | 283 | 0.040 |
Why?
|
| Cell Membrane | 2 | 1994 | 360 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 550 | 0.040 |
Why?
|
| Lasers | 1 | 1999 | 62 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 195 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1997 | 21 | 0.040 |
Why?
|
| Gene Library | 1 | 1997 | 55 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1997 | 175 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2001 | 1442 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 1996 | 61 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 430 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 455 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 1999 | 486 | 0.030 |
Why?
|
| Atenolol | 1 | 1994 | 4 | 0.030 |
Why?
|
| Propanolamines | 1 | 1994 | 12 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 103 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1994 | 50 | 0.030 |
Why?
|
| Brassica | 1 | 1994 | 14 | 0.030 |
Why?
|
| Plant Oils | 1 | 1994 | 17 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 1994 | 18 | 0.030 |
Why?
|
| Dermatitis | 1 | 2013 | 8 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 1993 | 2 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 57 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 71 | 0.030 |
Why?
|
| Melanins | 1 | 2013 | 32 | 0.030 |
Why?
|
| Cotinine | 1 | 1993 | 40 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 1993 | 7 | 0.030 |
Why?
|
| Adult | 3 | 2013 | 11034 | 0.030 |
Why?
|
| Choline | 1 | 1993 | 57 | 0.030 |
Why?
|
| Hemolysis | 1 | 1993 | 39 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1994 | 127 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 109 | 0.030 |
Why?
|
| Cytosol | 1 | 1992 | 85 | 0.030 |
Why?
|
| Bicarbonates | 1 | 1992 | 12 | 0.030 |
Why?
|
| Hematocrit | 1 | 1992 | 18 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1992 | 74 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1992 | 101 | 0.030 |
Why?
|
| Diglycerides | 1 | 1991 | 10 | 0.030 |
Why?
|
| Submandibular Gland Neoplasms | 1 | 1990 | 2 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 445 | 0.020 |
Why?
|
| Fetus | 1 | 1991 | 103 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1991 | 186 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 901 | 0.020 |
Why?
|
| NAD | 1 | 1990 | 39 | 0.020 |
Why?
|
| Convulsants | 1 | 1989 | 5 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1989 | 34 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1989 | 33 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 459 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1990 | 101 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 1988 | 83 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1987 | 49 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1988 | 82 | 0.020 |
Why?
|
| Glutathione | 1 | 1988 | 160 | 0.020 |
Why?
|
| Reducing Agents | 1 | 2006 | 13 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2006 | 21 | 0.020 |
Why?
|
| Enzymes | 1 | 2006 | 30 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 86 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 228 | 0.020 |
Why?
|
| Binding Sites | 1 | 1987 | 597 | 0.020 |
Why?
|
| Acute Disease | 1 | 2006 | 141 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 182 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 4012 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 5035 | 0.010 |
Why?
|